Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

R&D Expenses

$3.96B

TTM · Period ending: Jun 30, 2026 · USD

VRTX R&D Expenses

Latest reported$3.96Bperiod endingJun 30, 2026

Latest reported$3.96Bperiod endingJun 30, 2026

VRTX TTM R&D Expenses ($0.00 → $3.96B)

TTM R&D Expenses

High-resolution chart · PNG

VRTX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	100,406,000
Mar 31, 2001	92,436,000
Dec 31, 2000	84,921,000
Sep 30, 2000	77,876,000
Jun 30, 2000	72,928,000
Mar 31, 2000	72,104,000
Dec 31, 1999	72,100,000
Sep 30, 1999	72,100,000
Jun 30, 1999	71,400,000
Mar 31, 1999	65,000,000
Dec 31, 1998	58,600,000
Sep 30, 1998	54,500,000
Jun 30, 1998	55,200,000
Mar 31, 1998	53,400,000
Dec 31, 1997	51,500,000
Sep 30, 1997	45,400,000
Jun 30, 1997	37,500,000
Mar 31, 1997	36,200,000
Dec 31, 1996	35,200,000
Sep 30, 1996	35,700,000
Jun 30, 1996	35,800,000
Mar 31, 1996	41,400,000
Dec 31, 1995	41,500,000
Sep 30, 1995	33,100,000
Jun 30, 1995	24,500,000
Mar 31, 1995	9,400,000
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.